Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is an investigational topical herbal treatment consisting of pomegranate (*Punica granatum*) seed and peel extracts formulated as gels for the management of atrophic oral lichen planus. Developed by researchers at Cairo University and the National Research Centre in Cairo, Egypt, the treatment utilizes bioactive phytochemicals—including phenolic acids, tannins, anthocyanins, and flavonoids—to provide anti-inflammatory and antioxidant effects. It was evaluated in a randomized clinical trial (NCT04193748) involving 42 patients, where it demonstrated significant efficacy in reducing pain and clinical signs of oral lichen planus compared to triamcinolone acetonide. The treatment is a botanical extract modality rather than a synthetic small molecule or biologic.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pomegranate seed and peel extracts gel.